$521 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 65 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 36.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| APRE | Buy | APREA THERAPEUTICS | $51,109,000 | -24.3% | 1,470,340 | +0.0% | 9.81% | -2.6% |
| TDOC | Sell | TELADOC HEALTH | $27,262,000 | +9.0% | 175,875 | -41.1% | 5.23% | +40.3% |
| BMRN | Sell | BIOMARIN PHARMAC INC | $15,549,000 | -17.9% | 184,011 | -17.8% | 2.98% | +5.7% |
| BSX | Sell | BOSTON SCIENTIFIC | $15,478,000 | -34.0% | 474,334 | -8.5% | 2.97% | -15.1% |
| FOLD | Sell | AMICUS THERAPEUTICS | $14,396,000 | -28.2% | 1,557,961 | -24.4% | 2.76% | -7.7% |
| PTCT | Sell | PTC THERAPEUTICS I | $13,331,000 | -15.6% | 298,844 | -9.1% | 2.56% | +8.6% |
| TNDM | Sell | TANDEM DIABETES CARE | $12,565,000 | -38.3% | 195,264 | -42.9% | 2.41% | -20.6% |
| SRPT | Buy | SAREPTA THERAPEUTICS | $12,400,000 | +69.3% | 126,759 | +123.3% | 2.38% | +117.7% |
| SGEN | Buy | SEATTLE GENETICS INC | $12,346,000 | +620.3% | 107,000 | +613.3% | 2.37% | +825.8% |
| EXEL | New | EXELIXIS INC | $12,193,000 | – | 708,090 | +100.0% | 2.34% | – |
| HRC | Sell | HILL-ROM HLDS INC | $11,780,000 | -15.4% | 117,099 | -4.5% | 2.26% | +8.9% |
| FGEN | Sell | FIBROGEN INC | $11,659,000 | -25.9% | 335,506 | -8.5% | 2.24% | -4.6% |
| BIIB | Buy | BIOGEN INC | $11,387,000 | +17.9% | 35,992 | +10.6% | 2.19% | +51.7% |
| BMY | Sell | BRISTOL MYERS SQUIBB | $10,701,000 | -24.0% | 191,974 | -12.5% | 2.05% | -2.3% |
| RETA | Sell | REATA PHARMACEUTIC | $10,682,000 | -35.2% | 74,009 | -8.2% | 2.05% | -16.6% |
| IMMU | Buy | IMMUNOMEDICS INC | $10,273,000 | -29.9% | 762,123 | +10.1% | 1.97% | -9.7% |
| APLS | Sell | APELLIS PHARMACEUTIC | $10,151,000 | -27.2% | 378,923 | -16.8% | 1.95% | -6.3% |
| ACAD | Buy | ACADIA PHARMACEUTCLS | $10,032,000 | +62.3% | 237,450 | +64.4% | 1.93% | +108.9% |
| TRHC | Sell | TABULA RASA HEALTH | $9,211,000 | -8.7% | 176,156 | -15.0% | 1.77% | +17.5% |
| GBT | Buy | GLOBAL BLOOD THERA | $9,058,000 | -34.7% | 177,294 | +1.5% | 1.74% | -16.0% |
| ASMB | Sell | ASSEMBLY BIOSCIENCES | $9,039,000 | -36.2% | 609,494 | -12.0% | 1.74% | -18.0% |
| ATRC | Sell | ATRICURE INC | $8,619,000 | -50.3% | 256,606 | -51.9% | 1.66% | -36.1% |
| ALNY | Sell | ALNYLAM PHARMACUETCL | $8,469,000 | -16.1% | 77,800 | -11.2% | 1.63% | +8.0% |
| DCPH | New | DECIPHERA PHARMACEUT | $8,401,000 | – | 204,059 | +100.0% | 1.61% | – |
| RCM | Sell | R1 RCM INC | $8,395,000 | -44.2% | 923,573 | -20.3% | 1.61% | -28.2% |
| HMSY | Buy | HMS HOLDINGS CORP | $8,091,000 | -9.0% | 320,175 | +6.6% | 1.55% | +17.1% |
| PPD | New | PPD INC | $7,967,000 | – | 447,333 | +100.0% | 1.53% | – |
| MRK | Sell | MERCK & CO INC | $7,879,000 | -23.6% | 102,400 | -9.7% | 1.51% | -1.8% |
| QURE | Buy | UNIQURE N.V. | $7,753,000 | +23.7% | 163,400 | +86.7% | 1.49% | +59.0% |
| AZN | Buy | ASTRAZENECAsponsored adr | $7,405,000 | -5.9% | 165,800 | +5.1% | 1.42% | +21.0% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES | $7,340,000 | -21.6% | 90,225 | -34.4% | 1.41% | +0.9% |
| EVH | Sell | EVOLENT HEALTH INC | $7,307,000 | -59.6% | 1,345,672 | -32.7% | 1.40% | -48.0% |
| COLL | Sell | COLLEGIUM PHARMACEUT | $7,259,000 | -53.5% | 444,521 | -41.3% | 1.39% | -40.1% |
| CI | Sell | CIGNA CORP | $6,911,000 | -35.1% | 39,007 | -25.1% | 1.33% | -16.5% |
| SILK | Buy | SILK ROAD MEDICAL | $6,907,000 | +0.5% | 219,400 | +28.9% | 1.33% | +29.2% |
| TFX | Sell | TELEFLEX INC | $6,837,000 | -37.5% | 23,347 | -19.7% | 1.31% | -19.6% |
| INSP | Sell | INSPIRE MED SYS INC | $6,806,000 | -55.3% | 112,900 | -44.9% | 1.31% | -42.5% |
| CHNG | Buy | CHANGE HEALTHCARE IN | $6,462,000 | +8.7% | 646,895 | +78.4% | 1.24% | +39.8% |
| ABBV | New | ABBVIE INC | $6,381,000 | – | 83,750 | +100.0% | 1.22% | – |
| AERI | Sell | AERIE PHARMACEUTIC | $6,097,000 | -66.3% | 451,631 | -39.7% | 1.17% | -56.7% |
| ABT | Sell | ABBOTT LABS | $5,816,000 | -13.3% | 73,698 | -4.5% | 1.12% | +11.6% |
| PRAH | PRA HEALTH SCIENCE | $5,806,000 | -25.3% | 69,915 | 0.0% | 1.12% | -3.9% | |
| CSII | Sell | CARDIOVASCULAR SYS | $5,705,000 | -42.9% | 162,032 | -21.3% | 1.10% | -26.6% |
| MRTX | New | MIRATI THERAPEUTICS | $5,696,000 | – | 74,100 | +100.0% | 1.09% | – |
| TPTX | New | TURNING POINT THERAP | $5,261,000 | – | 117,800 | +100.0% | 1.01% | – |
| LLY | Sell | LILLY ELI & CO | $4,899,000 | -43.3% | 35,315 | -46.3% | 0.94% | -27.1% |
| UNH | Sell | UNITEDHEALTH GRP INC | $4,854,000 | -20.3% | 19,464 | -6.1% | 0.93% | +2.5% |
| MTEM | Sell | MOLECULAR TEMPLATES | $4,845,000 | -19.9% | 364,585 | -15.7% | 0.93% | +3.0% |
| GILD | Buy | GILEAD SCIENCES INC | $4,758,000 | +42.6% | 63,650 | +24.0% | 0.91% | +83.3% |
| VRTX | Buy | VERTEX PHARMACEUTICL | $3,848,000 | +9.3% | 16,171 | +0.6% | 0.74% | +40.8% |
| REGN | New | REGENERON PHARMCTCLS | $3,794,000 | – | 7,770 | +100.0% | 0.73% | – |
| MDT | Sell | MEDTRONIC PLC | $3,765,000 | -39.8% | 41,751 | -24.3% | 0.72% | -22.6% |
| NXTC | Sell | NEXTCURE INC | $3,675,000 | -47.8% | 99,149 | -20.7% | 0.70% | -32.9% |
| RCUS | New | ARCUS BIOSCIENCES | $3,626,000 | – | 261,213 | +100.0% | 0.70% | – |
| AMGN | Sell | AMGEN INC | $2,920,000 | -26.2% | 14,403 | -12.2% | 0.56% | -4.9% |
| ILMN | Sell | ILLUMINA INC | $2,439,000 | -24.6% | 8,930 | -8.4% | 0.47% | -3.1% |
| VCRA | Sell | VOCERA COMMUNICATI | $1,442,000 | -88.1% | 67,896 | -88.4% | 0.28% | -84.7% |
| INCY | Buy | INCYTE CORPORATION | $1,245,000 | -5.0% | 17,000 | +13.3% | 0.24% | +22.6% |
| PFE | New | PFIZER INC | $1,142,000 | – | 35,000 | +100.0% | 0.22% | – |
| MGTX | Sell | MEIRAGTX HLDINGS PLC | $867,000 | -53.6% | 64,534 | -30.8% | 0.17% | -40.5% |
| MRNA | New | MODERNA INC | $659,000 | – | 22,000 | +100.0% | 0.13% | – |
| GH | New | GUARDANT HEALTH INC | $644,000 | – | 9,250 | +100.0% | 0.12% | – |
| FIXX | Sell | HOMOLOGY MEDICINES | $595,000 | -34.2% | 38,281 | -12.4% | 0.11% | -15.6% |
| CRSP | New | CRISPR THERAPEUTICS | $456,000 | – | 10,750 | +100.0% | 0.09% | – |
| RDY | Sell | DR REDDYS LABS LTDadr | $297,000 | -52.9% | 7,354 | -52.7% | 0.06% | -39.4% |
| UMRX | Exit | UNUM THERAPEUTICS | $0 | – | -146,745 | -100.0% | -0.02% | – |
| SAGE | Exit | SAGE THERAPEUTICS | $0 | – | -7,650 | -100.0% | -0.08% | – |
| PHAS | Exit | PHASEBIO PHARMACEU | $0 | – | -178,000 | -100.0% | -0.16% | – |
| AGIO | Exit | AGIOS PHARMACEUTIC | $0 | – | -34,100 | -100.0% | -0.24% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -138,000 | -100.0% | -0.36% | – |
| EVLO | Exit | EVELO BIOSCIENCES | $0 | – | -632,582 | -100.0% | -0.38% | – |
| ALXN | Exit | ALEXION PHARM INC | $0 | – | -25,399 | -100.0% | -0.41% | – |
| BPMC | Exit | BLUEPRINT MEDICINES | $0 | – | -45,000 | -100.0% | -0.54% | – |
| TMO | Exit | THERMO FISHER SCI | $0 | – | -11,750 | -100.0% | -0.57% | – |
| ZBH | Exit | ZIMMER BIOMET HLDS | $0 | – | -49,249 | -100.0% | -1.10% | – |
| STML | Exit | STEMLINE THERAPEUT | $0 | – | -1,023,159 | -100.0% | -1.62% | – |
| PTLA | Exit | PORTOLA PHARMACEUTIC | $0 | – | -606,189 | -100.0% | -2.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.